Dr. Mrinalini Dey of London was invited to present her research at the 2023 Rheumatology Research Workshop in Orlando. She describes the experience here.
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of a Difficult-to-Treat Disease
Difficult-to-treat rheumatoid arthritis (RA) is defined as the failure of two or more classes of biologic or targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) to control active or progressive disease in patients with RA. Between 5 and 20% of patients with RA have difficult-to-treat RA.
FDA Proposal for Biosimilar Use in 2025 Budget
A proposal for biosimilar use in the 2025 budget would allow substitution of any biosimilar for its reference product without an interchangeable designation. The hope is to increase biosimilar uptake, with the subsequent potential to increase product “competition, access and affordability.”1 In the 2025 budget proposal, the Biden administration noted that the legal distinction between…
The Biases We Don’t Know We Hold
Implicit bias can affect patient care at the physician level when they’re making treatment decisions and at the healthcare organization level when they’re choosing new hires. Here are insights into strategies rheumatologists can use to become aware of, and question, their implicit biases.
Mental Health in Rheumatology
Regaining a sense of control, limiting responsibilities and engaging in mindfulness can help rheumatologists manage their mental health needs. Rheumatologists should also address the mental health concerns raised by their patients. Here are insights from a psychiatrist/rheumatologist.
ACR Voices Support for the Healthcare Workforce Resilience Act
The ACR joined with 52 organizations in thanking House and Senate leaders for introducing the Healthcare Workforce Resilience Act, which would support employment-based visas for international physicians and nurses.
Spring 2024 State Legislative Update
The ACR is actively monitoring more than 60 pieces of legislation, focusing on such key issues as copay accumulators, utilization management reform, gold card programs and other emerging concerns. Two states have passed utilization management reform bills this year.
HR & Other Aspects of Private Practice: A Conversation with Tien-I Karleen Su, MD, FACR
Despite challenges, private practice has many rewards, such as more autonomy, says Tien-I Karleen Su, MD, FACR, chair of the ACR’s Community Practice Council.
Interferons in Systemic Lupus Erythematosus
Current knowledge of receptor-ligand interactions, cell signaling, and transcriptional regulation derive from studies of type I interferon. The design of novel therapeutics is informed by the advances in investigation of type I interferon, with the potential for important impacts on patient management.
Rheum for Everyone, Episode 6: What Others Hear When You Ask ‘Where Are You From?’
In this episode, Dr. Kumar discusses brief, everyday exchanges that send denigrating messages to certain individuals because of their group membership.
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 803
- Next Page »